LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the European Patent Office (EPO) ...
LANGHORNE, Pa., December 02, 2025--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the European ...
ORLANDO, Fla.--(BUSINESS WIRE)--AireHealth, an innovative digital health company empowering and improving healthy living through affordable treatments, symptom tracking and early detection of ...
SHENZHEN, CHINA, March 7, 2025 / EINPresswire.com / -- Recently Shenzhen Loxim Technologies Co., Ltd. (LOXIM) has unveiled its latest innovation, the LX8201-0B chip, a dedicated drive solution for ...
Mesh nebulizers have more frequent drug side effects and may cause a higher increase in heart rate than compressor nebulizers in pediatric patients with asthma. Pediatric patients with asthma using ...
Introduction: Platelet lysate (PL) demonstrates antimicrobial and anti-inflammatory properties offering potential for treatment of bacterial pneumonia in horses. It remains unknown whether ...
After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer therapy ...
An ordinary home network router with a Wi-Fi 5 or Wi-Fi 6 access point is usually enough for most homes with a modest living space and central internet serving phones, laptops, and other everyday ...
PORTLAND, Ore. (KTVZ) – Drug delivery researchers at Oregon State University have developed a device with the potential to improve gene therapy for patients with inherited lung diseases such as cystic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback